{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:07:51Z","timestamp":1784891271411,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.parkreldis.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T18:17:03Z","timestamp":1538417823000},"page":"211-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Single center experience with medical cannabis in Gilles de la Tourette syndrome"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-8120","authenticated-orcid":false,"given":"Avner","family":"Thaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Arad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihi Bar-Lev","family":"Schleider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Knaani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Taichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1482-8522","authenticated-orcid":false,"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.10.004_bib1","doi-asserted-by":"crossref","first-page":"16097","DOI":"10.1038\/nrdp.2016.97","article-title":"Gilles de la Tourette syndrome","volume":"3","author":"Robertson","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.parkreldis.2018.10.004_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0447.2001.00147.x","article-title":"Quality of life (QOL) of patients with Gilles de la Tourette's syndrome","volume":"103","author":"Elstner","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib3","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/mds.26766","article-title":"The prevalence of diagnosed tourette syndrome in Canada: a national population-based study","volume":"31","author":"Yang","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000337376","article-title":"Is there any clinically relevant cannabinoid-induced analgesia?","volume":"89","author":"Kraft","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.parkreldis.2018.10.004_bib6","first-page":"CD006565","article-title":"Cannabinoids for Tourette's syndrome","author":"Curtis","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fpsyt.2016.00097","article-title":"Comorbidities, social impact, and quality of life in tourette syndrome","volume":"7","author":"Eapen","year":"2016","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","article-title":"Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome","volume":"72","author":"Hirschtritt","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.parkreldis.2018.10.004_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"Muller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.parkreldis.2018.10.004_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial","volume":"64","author":"Muller-Vahl","year":"2003","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.parkreldis.2018.10.004_bib12","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018304292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018304292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:23Z","timestamp":1761178583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018304292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":12,"alternative-id":["S1353802018304292"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single center experience with medical cannabis in Gilles de la Tourette syndrome","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}